litlas
Log inCreate account

Håkan Emanuelsson

Active 1985–2020

40
Papers
21,407
Citations
39
h-index
40
i10-index

Citations

Citations per year for Håkan Emanuelsson1985: 1 citations1986: 2 citations1987: 1 citations1988: 1 citations1990: 2 citations1991: 2 citations1992: 7 citations1993: 9 citations1994: 11 citations1995: 37 citations1996: 69 citations1997: 99 citations1998: 117 citations1999: 94 citations2000: 126 citations2001: 106 citations2002: 86 citations2003: 81 citations2004: 82 citations2005: 80 citations2006: 68 citations2007: 76 citations2008: 61 citations2009: 90 citations2010: 142 citations2011: 147 citations2012: 121 citations2013: 129 citations2014: 116 citations2015: 108 citations2016: 86 citations2017: 91 citations2018: 69 citations2019: 360 citations2020: 295 citations2021: 204 citations2022: 167 citations2023: 128 citations2024: 172 citations2025: 64 citations2026: 1 citations1989: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,305 citing papers, 21% of this breakdownUnited Kingdom: 494 citing papers, 8% of this breakdownGermany: 419 citing papers, 6.8% of this breakdownItaly: 415 citing papers, 6.7% of this breakdownNetherlands: 369 citing papers, 5.9% of this breakdownFrance: 319 citing papers, 5.1% of this breakdownCanada: 284 citing papers, 4.6% of this breakdownSweden: 263 citing papers, 4.2% of this breakdownChina: 190 citing papers, 3.1% of this breakdownSwitzerland: 173 citing papers, 2.8% of this breakdownJapan: 171 citing papers, 2.8% of this breakdownSpain: 143 citing papers, 2.3% of this breakdown
0%21%Other 26.7%

Institutions

Fields

  • Medicine92.2%
  • Biochemistry, Genetics and Molecular Biology2.7%
  • Materials Science1.4%
  • Immunology and Microbiology0.7%
  • Engineering0.6%
  • Pharmacology, Toxicology and Pharmaceutics0.6%
  • Other1.8%

Topics

  • Antiplatelet Therapy and Cardiovascular Diseases14.1%
  • Coronary Interventions and Diagnostics13.6%
  • Acute Myocardial Infarction Research11%
  • Cardiac Imaging and Diagnostics6.5%
  • Atrial Fibrillation Management and Outcomes4.5%
  • Venous Thromboembolism Diagnosis and Management2.7%
  • Other47.6%

Coauthors

All papers

Open in search
  1. Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes

    Authors: Lars Wallentin, Richard C. Becker, Andrzej Budaj, Christopher P. Cannon, Håkan Emanuelsson, Claes Held, Jay Horrow, Steen Husted, Stefan James, Hugo A. Katus, Kenneth W. Mahaffey, Benjamin M. Scirica, Allan M. Skene, Philippe Gabríel Steg, Robert F. Storey, Robert A. Harrington - New England Journal of Medicine 2009 cited by 7,070

  2. A Comparison of Balloon-Expandable-Stent Implantation with Balloon Angioplasty in Patients with Coronary Artery Disease

    Authors: Patrick W. Serruys, Peter de Jaegere, Ferdinand Kiemeneij, Carlos Macaya, Wolfgang Rutsch, Guy R. Heyndrickx, Håkan Emanuelsson, Jean Marco, Victor Legrand, Pierre Materne, Jorge Belardi, Ulrich Sigwart, Antonio Colombo, J J Goy, Paul van den Heuvel, Juan L. Delcán, Marie‐Angèle Morel - New England Journal of Medicine 1994 cited by 4,550

  3. Ticagrelor vs. Clopidogrel in Japanese, Korean and Taiwanese Patients With Acute Coronary Syndrome – Randomized, Double-Blind, Phase III PHILO Study –

    Authors: Shinya Goto, Chien‐Hua Huang, Seung‐Jung Park, Håkan Emanuelsson, Takeshi Kimura - Circulation Journal 2015 cited by 280

  4. Inhibitory Effects of Ticagrelor Compared With Clopidogrel on Platelet Function in Patients With Acute Coronary Syndromes

    Authors: Robert F. Storey, Dominick J. Angiolillo, Shankar B. Patil, Bhaloo Desai, Rosemary Ecob, Steen Husted, Håkan Emanuelsson, Christopher P. Cannon, Richard C. Becker, Lars Wallentin - Journal of the American College of Cardiology 2010 cited by 368

  5. Ticagrelor Versus Clopidogrel in Patients With ST-Elevation Acute Coronary Syndromes Intended for Reperfusion With Primary Percutaneous Coronary Intervention

    Authors: Philippe Gabríel Steg, Stefan James, Robert A. Harrington, Diego Ardissino, Richard C. Becker, Christopher P. Cannon, Håkan Emanuelsson, Ariel Finkelstein, Steen Husted, Hugo Katus, Jan Kilhamn, Sylvia Olofsson, Robert F. Storey, W. Douglas Weaver, Lars Wallentin, for the PLATO Study Group - Circulation 2010 cited by 504

  6. Inhibition of Platelet Aggregation by AZD6140, A Reversible Oral P2Y12Receptor Antagonist, Compared With Clopidogrel in Patients With Acute Coronary Syndromes

    Authors: Robert F. Storey, Steen Husted, Robert A. Harrington, S Heptinstall, Robert G. Wilcox, Gary Peters, Mark Wickens, Håkan Emanuelsson, Paul A. Gurbel, Peer Grande, Christopher P. Cannon - Journal of the American College of Cardiology 2007 cited by 486

  7. Pharmacodynamics, pharmacokinetics, and safety of the oral reversible P2Y12 antagonist AZD6140 with aspirin in patients with atherosclerosis: a double-blind comparison to clopidogrel with aspirin

    Authors: Steen Husted, Håkan Emanuelsson, Stan Heptinstall, Per Morten Sandset, Mark Wickens, Gary Peters - European Heart Journal 2006 cited by 740

  8. Comparison of ticagrelor with clopidogrel in patients with a planned invasive strategy for acute coronary syndromes (PLATO): a randomised double-blind study

    Authors: Christopher P. Cannon, Robert A. Harrington, Stefan James, Diego Ardissino, Richard C. Becker, Håkan Emanuelsson, Steen Husted, Hugo A. Katus, Mátyás Keltai, Nardev S. Khurmi, Frederic Kontny, Basil S. Lewis, Philippe Gabríel Steg, Robert F. Storey, Daniel Wojdyla, Lars Wallentin - The Lancet 2010 cited by 661

  9. Safety, Tolerability, and Initial Efficacy of AZD6140, the First Reversible Oral Adenosine Diphosphate Receptor Antagonist, Compared With Clopidogrel, in Patients With Non–ST-Segment Elevation Acute Coronary Syndrome

    Authors: Christopher P. Cannon, Steen Husted, Robert A. Harrington, Benjamin M. Scirica, Håkan Emanuelsson, Gary Peters, Robert F. Storey - Journal of the American College of Cardiology 2007 cited by 495

  10. Heparin-Coated Palmaz-Schatz Stents in Human Coronary Arteries

    Authors: Patrick W. Serruys, Håkan Emanuelsson, Wim van der Giessen, Anthony C. Lunn, Ferdinand Kiemeney, Carlos Macaya, Wolfgang Rutsch, Guy R. Heyndrickx, Harry Suryapranata, Victor Legrand, J J Goy, Pierre Materne, Hans Bonnier, Marie‐Claude Morice, Jean Fajadet, Jorge Belardi, Antonio Colombo, Eulogio Garcı́a, Peter Ruygrok, Peter de Jaegere, Marie‐Angèle Morel - Circulation 1996 cited by 404

  11. The Incidence of Bradyarrhythmias and Clinical Bradyarrhythmic Events in Patients With Acute Coronary Syndromes Treated With Ticagrelor or Clopidogrel in the PLATO (Platelet Inhibition and Patient Outcomes) Trial

    Authors: Benjamin M. Scirica, Christopher P. Cannon, Håkan Emanuelsson, Eric L. Michelson, Robert A. Harrington, Steen Husted, Stefan James, Hugo A. Katus, Prem Pais, Dimitar Raev, Jindřich Špinar, Philippe Gabríel Steg, Robert F. Storey, Lars Wallentin - Journal of the American College of Cardiology 2011 cited by 126

  12. Heparin coating of the stent graft — effects on platelets, coagulation and complement activation

    Authors: Kjeld Christensen, Rolf Larsson, Håkan Emanuelsson, Graciela Elgue, Anders Larsson - Biomaterials 2001 cited by 105

  13. The SYNTAX score on its way out or … towards artificial intelligence: part I

    Authors: Patrick W. Serruys, Ply Chichareon, Rodrigo Modolo, David M. Leaman, Johan H. C. Reiber, Håkan Emanuelsson, Carlo Di Mario, Nico H.J. Pijls, Marie-Angèle Morel, Marco Valgimigli, Vasim Farooq, David van Klaveren, Davide Capodanno, Daniele Andreini, Christos V. Bourantas, Justin E. Davies, Adrian Banning, Javier Escaned, Jan J. Piek, Mauro Echavarría‐Pinto, Charles A. Taylor, Brian Thomsen, Carlos Collet, Giulio Pompilio, Antonio L. Bartorelli, Ben Glocker, Ovidiu Dressler, Gregg W. Stone, Yoshinobu Onuma - EuroIntervention 2020 cited by 42

  14. Randomised comparison of implantation of heparin-coated stents with balloon angioplasty in selected patients with coronary artery disease (Benestent II)

    Authors: Patrick W Serruys, Ben van Hout, Hans Bonnier, Victor Legrand, Eulogio García, Carlos Macaya, Eduardo Sousa, Wim van der Giessen, Antonio Colombo, Ricardo Seabra‐Gomes, Ferdinand Kiemeneij, Peter Ruygrok, John Ormiston, Håkan Emanuelsson, Jean Fajadet, Michael Haude, Silvio Klugmann, Marie‐Angèle Morel - The Lancet 1998 cited by 655

  15. Randomized Evaluation of Anticoagulation Versus Antiplatelet Therapy After Coronary Stent Implantation in High-Risk Patients

    Authors: Philip Urban, Carlos Macaya, Hans‐Jürgen Rupprecht, Ferdinand Kiemeneij, Håkan Emanuelsson, Alessandro Fontanelli, Michael Pieper, Thea Wesseling, Luc Sagnard - Circulation 1998 cited by 446

  16. Comparison of ticagrelor, the first reversible oral P2Y12 receptor antagonist, with clopidogrel in patients with acute coronary syndromes: Rationale, design, and baseline characteristics of the PLATelet inhibition and patient Outcomes (PLATO) trial

    Authors: Stefan James, Axel Åkerblom, Christopher P. Cannon, Håkan Emanuelsson, Steen Husted, Hugo A. Katus, Allan M. Skene, Philippe Gabríel Steg, Robert F. Storey, Robert A. Harrington, Richard C. Becker, Lars Wallentin - American Heart Journal 2009 cited by 402

  17. Prognostic Value of Intracoronary Flow Velocity and Diameter Stenosis in Assessing the Short- and Long-term Outcomes of Coronary Balloon Angioplasty

    Authors: Patrick W. Serruys, Carlo Di Mario, Jan J. Piek, Erwin Schroëder, Christian Vrints, Peter Probst, Bernard De Bruyne, Claude Hanet, Eckart Fleck, Michael Haude, Edoardo Verna, Vasilis Voudris, H Geschwind, Håkan Emanuelsson, V. Mühlberger, Giambattista Danzi, Hans O. Peels, Andrew J. Ford, Eric Boersma - Circulation 1997 cited by 292

  18. Effects of spinal cord stimulation in angina pectoris induced by pacing and possible mechanisms of action.

    Authors: Clas Mannheimer, T. Eliasson, Bert Andersson, C.‐H. Bergh, L.-E. Augustinsson, Håkan Emanuelsson, Finn Waagstein - BMJ 1993 cited by 221

  19. Characterization of dyspnoea in PLATO study patients treated with ticagrelor or clopidogrel and its association with clinical outcomes

    Authors: Robert F. Storey, Richard C. Becker, Robert A. Harrington, Steen Husted, Stefan James, Frank Cools, Philippe Gabríel Steg, Nardev S. Khurmi, Håkan Emanuelsson, Anna Cooper, Richard Cairns, Christopher P. Cannon, Lars Wallentin - European Heart Journal 2011 cited by 203

  20. Ticagrelor Enhances Adenosine-Induced Coronary Vasodilatory Responses in Humans

    Authors: Ann Wittfeldt, Håkan Emanuelsson, Gunnar Brandrup‐Wognsen, J.J.J. van Giezen, Jenny Jonasson, Sven Nylander, Li‐Ming Gan - Journal of the American College of Cardiology 2013 cited by 196

  21. The effects of transcutaneous electrical nerve stimulation in patients with severe angina pectoris.

    Authors: Clas Mannheimer, C. Carlsson, Håkan Emanuelsson, A Vedin, Finn Waagstein, Claes Wilhelmsson - Circulation 1985 cited by 170

  22. Intracoronary pressure and flow velocity with sensor-tip guidewires: A new methodologic approach for assessment of coronary hemodynamics before and after coronary interventions

    Authors: Patrick W. Serruys, Carlo Di Mario, Nicolas Meneveau, Peter de Jaegere, Sipke Strikwerda, Pim J. de Feyter, Håkan Emanuelsson - The American Journal of Cardiology 1993 cited by 145

  23. Anti-Ischemic and Anti-Anginal Effects of Thoracic Epidural Anesthesia Versus Those of Conventional Medical Therapy in the Treatment of Severe Refractory Unstable Angina Pectoris

    Authors: Karin Olausson, Helga Magnúsdóttir, Leon Lurje, Bertil Wennerblom, Håkan Emanuelsson, Sven‐Erik Ricksten - Circulation 1997 cited by 117

  24. Spinal cord stimulation in angina pectoris with normal coronary arteriograms

    Authors: Tore Eliasson, Per Albertsson, Peter Hårdhammar, Håkan Emanuelsson, Lars‐Erik Augustinsson, Clas Mannheimer - Coronary Artery Disease 1993 cited by 80